The Sixty-Nine Days · claim M19

On September 10, 2026, Fundrise Innovation Fund, the New York Stock Exchange-listed vehicle that trades as VCX, registered to sell up to $1,000,000,000 of new shares through an at-the-market program with Jefferies. A registration of that kind sets a ceiling the fund may sell into at its own discretion over time; it is capacity, not an offer of a billion dollars of stock to anyone. The filing states its own numbers on the same page: the shares closed at $38.12 on September 8 and the fund's net asset value that day was $21.70 a share. Both figures are the fund's own, for the same day, printed on the same page. The market price is 75.7 percent above the asset value by arithmetic on those two numbers, which is ours, not a figure the filing states. The offering is priced off the market, not the asset value. The one price rule the filing imposes runs the other way: shares may not be sold below net asset value plus the agent's commission. That floor exists to protect existing holders from dilution. Nothing in the filing sets a ceiling on what a new buyer pays above it. Jefferies takes up to 3 percent of gross proceeds. The fund's portfolio report for June 30 shows $776,968,362 of net assets across 62 positions, of which the five largest, $333,826,743 or 43 percent, are reported as restricted limited-partnership interests carried at the filing's own fair-value level 3. The filing names not one company any of those five vehicles holds.

2026-09-10